Ribolib
Ribolib is Ribociclib, an oral CDK4/6 inhibitor. It is indicated for hormone receptor-positive, HER2-negative advanced or metastatic breast cancer and works by slowing cell-cycle progression through CDK4/6 inhibition.
Features
| Product Name | Ribolib |
| Generic Name | Ribociclib |
| Formulation | Tablet |
| Available Pack Size | 1X21's |
| Available Strength | 200 mg |